Immupharma Share Discussion Threads

[l0ngterm] 03/1/2018 18:43

If it helps zho, posters can be on multiple boards and frequently are. You may actually find that posters will gravitate to the B.B. most informative and active on the share. Not the company.If it helps I have invested for years, btg ( seen panic when ceo sold shares due to divorce nothing sinister)Vodaphone In at 1.12 roughly during the crunch out at 2.00 before the sold off their share in. Viacom (can't rember exactly) Similarly General Electric at 10.00 ( from memory).And failed in some banks as well.But this is for sure length of chain doesn't mean expert in any field. Those that have the experience don't start chucking the comment about easily. Nor do they rant about referenced material, as this is how universities and researchers work.They do however tend to impart knowledge. Not go wildly ramping and slinging accusations left right and centre.So stuff your experience and let's see what happens. Let's let the market dictate the price and respect the individuals opinions.Unless off course your just a keyboard warrior..

[l0ngterm] 03/1/2018 18:34

I did say that it was unique, in my experience, to find an investor commenting on just one company, 232 times in your own case. To spot 10 'investors' in a similar position within 48 hours, each with an all consuming interest in the very same company suggests an organised attempt to deceive.Try looking at content of posts, filter repeat posters. Rather than just rant about ooh these guys have been posting on here for years nonsense

[l0ngterm] 03/1/2018 18:30

ZHO: you mentioned cuts and pastes as if genuine research into the company would not involve such referenced material.You have had a pop at me and others etc. Stating "I am ramper " odd considering my estimations is £2-5 pre results which is close to where we are.You have attempted to leverage which I loathe " 30 years of experience". Which in my professional experience is usually individuals moon walking backwards out the door. I.e. provide insight or knowledge, but you seem to lack little in this department so "do hey I have done stuff for 30 years"Where as knowledge shared and discussed seems beyond you, sweeeping accusations however are not.Overall I do find you highly entertaining though.

[zho] 03/1/2018 17:14

Hi L0ngterm,

>>Zho I didn’t realise you had a lab, where you have conducted your own studies and have publicly published your findings and research to the scientific community. Can you please share your findings, lab results etc.

I will personally share these with the CNRS, IMM, FDA and others if your (sic) to (sic) shy to share? >>

Good to hear from you again. Waiting for your posts is like waiting for the first breath of spring.

I didn't make any comments about the science, as you know. I did say that it was unique, in my experience, to find an investor commenting on just one company, 232 times in your own case. To spot 10 'investors' in a similar position within 48 hours, each with an all consuming interest in the very same company suggests an organised attempt to deceive.

[wi1l] 03/1/2018 16:43

Thankfully these bb don't have any bearing on the share price and its a pity this ones reached rock bottom.

[topdiesel] 03/1/2018 16:22

I guess the market likes that I am Batman

[topdiesel] 03/1/2018 15:54

longterm...shhhh, lets keep that our little secret. Your sleuthing skills impress even me.

[l0ngterm] 03/1/2018 15:50

Top diesel: "Holly Cow" your secrets out, ZHO will catch you on that one.Your batman aka Bruce Wayne from the 70s.. kapoow... aren't you? You secret billionaire hero you :-)

[mustau] 03/1/2018 15:47

Immy, well done to u, I think your now ready to tie the knot!!

[topdiesel] 03/1/2018 15:45

holly cow, zho is right. I just posted and it bounced positive half a pence.

[hottingup] 03/1/2018 15:42

Hope you don't have a student debt. Got my Degree all free in the good old days.

[herschel k] 03/1/2018 15:41

thanks for making me feel old Immy. :)

[l0ngterm] 03/1/2018 15:41

Zho I didn't realise you had a lab, where you have conducted your own studies and have publicly published your findings and research to the scientific community. Can you please share your findings, lab results etc. I will personally share these with the CNRS, IMM, FDA and others if your to shy to share?

[hottingup] 03/1/2018 15:40

Immy, nice to have some young blood here.

[topdiesel] 03/1/2018 15:40

zho...good morning. My fame and notoriety will continue. I am not sorry you missed out on this share when it was cheap. I am happy I got in under 40p and have enjoyed the jump in value. I am happy because as njb has stated, the final valuation will be based on the value when a deal is struck. Go ahead and twist my words however you would like. It is like having my own fake news channel. zho is my CNN.

[immy1992] 03/1/2018 15:40

Actually no don't bother. Your opinion is like toilet paper to me. Have fun with yourself

[immy1992] 03/1/2018 15:39

I had spent my better part of a lot of days looking at my investment when I bought at 50p. I now know better then to argue with fools like you.

My original posts was disputing nibbys claims and then I discussed the spa and fast track. Find me one ramp that is prominent on this board from my user .

[zho] 03/1/2018 15:35

Hi immy1992,

>>You want science stuff go read my early posts.>>

I've had a quick look - mainly cut and paste. BTW, I notice you say that:


"I really have no clue about the science of it all and have spent the better part of the last few days looking into this."

immy1992 8 Sep '17 - 12:07 - 3463 of 8563

[l0ngterm] 03/1/2018 15:28

It has that immy, looking forward to the coming weeks. If only to cut out some of this noise.Gla and a happy new year to you all.

[zho] 03/1/2018 15:23

Hi immy1992,

>>I've been on this board for a while but haven't bothered posting ...>>

Er ... but you appear to have made 102 posts on IMM since the 4th September.

>> ... since none of the debate here has been about the science or anything substantial other then price valuation>>

Go on then, knock us out with some sciencey stuff.

>>Just Cause your (sic) blue doesn't mean you can mouth of.>>

Mouth of what?

>> Your more recent to this board then most>>

You're missing my point, presumably deliberately, and if you look at my profile you'll see that I signed up to ADVFN 18 years ago. The likes of topdiesel, L0ngterm, spmc, runtoma, ballsac, PostBrexit1, cammy5, stealth wealth, davew28 and your good self are recent ADVFN members who appear to have posted exclusively on IMM, leading me to suspect a coordinated attempt to pump up the price.

xxx

[top tips] 03/1/2018 15:20

Nice find L0ngterm. Heaven knows how much Nucant and the Urelix platform could be worth on top of Lupuzor P140 but it all adds up.

........................

a) Nucant (IPP-204106) (For cancer, age related macular degeneration (AMD) and diabetic retinopathy):

Combination therapy, using injections. Controlled & stopped growth of multiple human cancer cell lines in vitro + in vivo, i.e. breast cancer, prostate cancer, melanoma, glioblastoma, leukaemia, colon cancer & pancreatic cancer. In vivo studies - majority of tumours completely eradicated & survival time increased. Other potential indications include age related macular degeneration (AMD) & diabetic retinopathy.

Two Phase 1 studies completed for safety & tolerability. Phase 1/2a dose-finding adaptive study (with chondroitin sulphate) showed maximum tolerated dose 9 mg/kg (the primary objective of the study).

Phase 2a trial on patients who failed other cancer treatments & had metastases - 21% of patients with progressive disease stabilised for more than 6 months; one of the first patients still alive after 20 months. Revised formulation then trialled, shown to be 10x more potent in pre-clinical studies than the original.

EU grants received to develop Nucants in combination with cytotoxic drugs for solid support, & in age-related macular degeneration, diabetic retinopathy & other ophthalmological indications.

Phase 2 efficacy trial ready to start, for pancreatic cancer, involving pre-treatment with Nucant followed by standard dose of cytotoxic drug Gemicitabin. Future potential to target further cancer indications. (Robert Zimmer - Presentation Slide, July 2017 - Listen and see at 18 min 00 sec onwards:


b) URELIX (peptide platform technology - e.g. Type II diabetes and NASH):

Peptide to drug converting technology (PDCT) increases peptide’s plasma half-life & efficacy. May improve the oral absorption of small peptides, e.g. met-enkephalin (the body’s internal analgesic) which would be a major advance.

Development risk of drugs based on peptides should be significantly reduced because the peptides are produced by the human body & are therefore less likely to be rejected.

Technology allows outstanding properties in terms of duration of action. Next therapeutic areas to be targeted - Type II diabetes (390m sufferers) & NASH (Non-Alcoholic-Steato-Hepatitis) - both multi-billion $ markets. (Global Data recently valued potential in NASH at $25 billion in 2016, with double-digit increase per year).

[ny boy] 03/1/2018 15:17

May I suggest everyone goes on holidays for a few weeks, until more news breaks, to a warm climate & chill out like me! 😁

Seen three orange super moons in a row, must be a sign!

I’m expecting more thumbs up’s than remarkosoc